Free Trial

Allurion Technologies Q2 2023 Earnings Report

Allurion Technologies logo
$3.12 -0.33 (-9.57%)
As of 03:58 PM Eastern

Allurion Technologies EPS Results

Actual EPS
-$54.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Allurion Technologies Revenue Results

Actual Revenue
$12.96 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Allurion Technologies Announcement Details

Quarter
Q2 2023
Time
N/A

ALUR Upcoming Earnings

Allurion Technologies will be holding an earnings conference call on Wednesday, March 26 at 8:30 AM Eastern. Interested parties can register for or listen to the call or dial in at 800-770-2030 using passcode "1905455".

Remove Ads

Allurion Technologies Earnings Headlines

Top Penny Stocks To Follow Now - March 22nd
Allurion Technologies (NYSE:ALUR) Given Buy Rating at Roth Mkm
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Allurion Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Allurion Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allurion Technologies and other key companies, straight to your email.

About Allurion Technologies

Allurion Technologies (NYSE:ALUR) focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

View Allurion Technologies Profile

More Earnings Resources from MarketBeat